Dianthus Therapeutics, Inc. (DNTH) — Dilution Risk Analysis

Current Snapshot

Dianthus Therapeutics, Inc. (DNTH) has a DilutionWatch score of 29/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Dilution Risk Score

Score: 29/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

2 shelf registration or ATM offering filings detected in recent history.

Recent filing forms in the source payload: 4 7, 8-K 1, 424B5 2.

Form	Filed	Accession
4	2026-03-13	0001992260-26-000004
4	2026-03-13	0001273351-26-000004
4	2026-03-13	0001669866-26-000005
8-K	2026-03-12	0001193125-26-103053
424B5	2026-03-11	0001193125-26-102472
424B5	2026-03-09	0001193125-26-098846
4	2026-02-04	0001669866-26-000002
4	2026-02-04	0001992324-26-000002
4	2026-02-04	0001992260-26-000002
4	2026-02-04	0001778623-26-000002

Dilution Risk Drivers

Driver	Stored Value	Source
Shelf registration capacity	$600,000,000	Source
ATM offering capacity remaining	$100,100,000	Source
Cash runway	99 months	Source
Three-year share count growth	277.48%	Source

DilutionWatch Analysis

Risk Level: MEDIUM (Score: 29/10) Source
Cash Runway: 99 months Source
ATM Offering Capacity Remaining: $100,100,000 Source
Shelf Registration Capacity: $600,000,000 Source
Share Count Growth (3-Year): 277.48% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.